Immix Biopharma (IMMX) Proxy Filing summary

Executive summary

• Annual Meeting of Stockholders scheduled for June 20, 2025, at the company's Los Angeles office.

• Proxy materials and 2024 Annual Report on Form 10-K are available online for review prior to voting.

• Stockholders are encouraged to review all proxy materials before voting by mail, online, or in person.

Voting matters and shareholder proposals

• Election of eight directors is up for shareholder vote.

• Ratification of Crowe LLP as independent registered public accounting firm for fiscal year ending December 31, 2025.

• Board recommends voting "FOR" all director nominees and the auditor ratification proposal.

Board of directors and corporate governance

• Ilya Rachman serves as Chairman and Chief Executive Officer and has signed the notice on behalf of the Board.